A Prospective Study on the Efficacy and Safety of a Novel Oral Drug, Etrasimod, in Elderly Patients With Ulcerative Colitis
Status: Recruiting
Location: See location...
Intervention Type: Drug
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY
Eligible patients will be identified in regular clinical practice. After providing thorough explanation and obtaining voluntary written informed consent, the clinical course, adverse events, endoscopic findings, and histopathological changes in biopsy specimens after Etrasimod administration will be prospectively collected and analyzed.
Eligibility
Participation Requirements
Sex: All
Healthy Volunteers: f
View:
• Patients with active ulcerative colitis
Locations
Other Locations
Japan
Showa Inan General Hospital
RECRUITING
Komagane
Contact Information
Primary
Norio Saegusa
ikyoku.tosho@sihp.jp
81265822121
Time Frame
Start Date: 2025-10-01
Estimated Completion Date: 2026-09-30
Participants
Target number of participants: 30
Treatments
Experimental: elderly patients (aged 65 years or older) with active ulcerative colitis
Related Therapeutic Areas
Sponsors
Leads: Showa Inan General Hospital